Progranulin is a good predictive biomarker in ovarian cancer patients followed in first remission

被引：0
|
作者：
Han, Jasmine J.
Yu, Minshu
Hays, John L.
Kohn, Elise C.
机构：
来源：
CANCER RESEARCH | 2010年 / 70卷
关键词：
D O I：
10.1158/1538-7445.AM10-828
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
828
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Progranulin as a prognostic biomarker of advanced epithelial ovarian cancer
    Fitzgerald, Sharon
    Yu, Minshu
    Hays, John
    Di Santo, Nicola
    Havrilesky, Laura
    Kohn, Elise
    [J]. CANCER RESEARCH, 2013, 73 (08)
  • [2] MUTYH as an Emerging Predictive Biomarker in Ovarian Cancer
    Hutchcraft, Megan L.
    Gallion, Holly H.
    Kolesar, Jill M.
    [J]. DIAGNOSTICS, 2021, 11 (01)
  • [3] Galectin-1 as a predictive biomarker in ovarian cancer
    Masoodi, Mahak
    Shah, Zafar A.
    Beigh, Afaq H.
    Ahmad, Sheikh Zahoor
    Mir, Abdul Wahid
    Yasin, Besina
    Rasool, Roohi
    Masoodi, Khalid Z.
    Bhat, Gull Mohammad
    [J]. JOURNAL OF OVARIAN RESEARCH, 2021, 14 (01)
  • [4] Galectin-1 as a predictive biomarker in ovarian cancer
    Mahak Masoodi
    Zafar A. Shah
    Afaq H. Beigh
    Sheikh Zahoor Ahmad
    Abdul Wahid Mir
    Besina Yasin
    Roohi Rasool
    Khalid Z. Masoodi
    Gull Mohammad Bhat
    [J]. Journal of Ovarian Research, 14
  • [5] Microvascular Density as a Predictive Biomarker for Bevacizumab Survival Benefit in Ovarian Cancer: Back to First Principles?
    Ferrara, Napoleone
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2017, 109 (11)
  • [6] CANCER STEM CELL MARKER EpCAM AS A PREDICTIVE BIOMARKER OF CHEMOTHERAPEUTIC RESPONSE IN PATIENTS WITH EPITHELIAL OVARIAN CANCER
    Iwagoi, Y.
    Motohara, T.
    Tayama, S.
    Motooka, Y.
    Narantuya, D.
    Sakaguchi, I.
    Honda, R.
    Tashiro, H.
    Katabuchi, H.
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2018, 28 : 713 - 713
  • [7] Challenging the dogma that first remission is the longest in patients (pts) with advanced ovarian cancer (AOC)
    Benafif, Sarah
    Carter, Thomas
    Rustin, Gordon J. S.
    Hall, Marcia
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [8] Plasma miRNAs as potential predictive/prognostic biomarker for ovarian cancer
    Chen, Kexin
    [J]. CANCER RESEARCH, 2012, 72
  • [9] Sequentially insert of carboplatin followed by Paclitaxel in the first-line therapy for ovarian cancer carboplatin followed by Paclitaxel in the therapy for ovarian cancer
    Sehouli, J.
    Mustea, A.
    Pfisterer, J.
    Camara, O.
    Lichtenegger, W.
    Oskay-Oezcelik, G.
    [J]. GEBURTSHILFE UND FRAUENHEILKUNDE, 2008, 68 : S70 - S70
  • [10] CD44 Variant 6 as a Predictive Biomarker for Distant Metastasis in Patients With Epithelial Ovarian Cancer
    Motohara, Takeshi
    Fujimoto, Koichi
    Tayama, Shingo
    Narantuya, Dashdemberel
    Sakaguchi, Isao
    Tashiro, Hironori
    Katabuchi, Hidetaka
    [J]. OBSTETRICS AND GYNECOLOGY, 2016, 127 (06): : 1003 - 1011
12345